 |
| Attached files |
| File | Filename |
|---|
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R12.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R20.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R38.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R27.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R10.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R5.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R41.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R26.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R21.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R34.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R16.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R14.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R13.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R15.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R19.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R23.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R11.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R4.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R18.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R1.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R17.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R3.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R7.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R24.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R36.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R22.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R35.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R6.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R2.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R40.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R32.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R8.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R31.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R30.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R44.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R28.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R29.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R43.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | Financial_Report.xls |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R9.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R37.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R42.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R25.htm |
| XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC. | R39.htm |
| EX-10.39 - EXHIBIT 10.39 - ENTEST BIOMEDICAL, INC. | entb0129form10kex1039.htm |
| EX-10.37 - EXHIBIT 10.37 - ENTEST BIOMEDICAL, INC. | entb0129form10kex1037.htm |
| EX-32.2 - EXHIBIT 32.2 - ENTEST BIOMEDICAL, INC. | entb0129form10kex322.htm |
| EX-32.1 - EXHIBIT 32.1 - ENTEST BIOMEDICAL, INC. | entb0129form10kex321.htm |
| EX-31.2 - EXHIBIT 31.2 - ENTEST BIOMEDICAL, INC. | entb0129form10kex312.htm |
| EX-31.1 - EXHIBIT 31.1 - ENTEST BIOMEDICAL, INC. | entb0129form10kex311.htm |
| 10-K - FORM 10-K - ENTEST BIOMEDICAL, INC. | entb0129form10k.htm |
v2.4.0.6
|
RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)
|
3 Months Ended |
|
|
May 31, 2012
|
Feb. 29, 2012
|
Nov. 30, 2011
|
Aug. 31, 2012
|
| Related Party Transactions [Abstract] |
|
|
|
|
| Loans made to Company by David Koos |
$ 13,625 |
$ 7,550 |
$ 8,400 |
|
| Loan simple interest rate per annum |
15.00% |
15.00% |
15.00% |
|
| Unpaid indebtedness |
|
25,956 |
|
|
| Unpaid indebtedness interest rate per annum |
|
15.00% |
|
|
| Unpaid interest |
|
3,051 |
|
|
| Indebted to David Koos, principal |
|
|
|
30,180 |
| Indebted to David Koos, interest rate per annum |
|
|
|
15.00% |
| Indebted to Bio-Matrix Scientific Group, Inc. |
|
|
|
$ 39,140 |
| X |
- Definition
Total current liabilities of the broker-dealer, less certain exceptions as defined.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Rule 15c3
-Number 240
-Section 1
-Paragraph 1
-Subparagraph i
-Article 15c3
-Subsection a
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Rule 15c3
-Number 240
-Section 1
-Paragraph 1
-Article 15c3
-Subsection c
+ Details
| Name: |
us-gaap_AggregateIndebtedness |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
credit |
| Period Type: |
instant |
|
| X |
- Definition
The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 32
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586
+ Details
| Name: |
us-gaap_DebtConversionOriginalDebtInterestRateOfDebt |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
num:percentItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
Increase for accrued, but unpaid interest on the debt instrument for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph f
-Article 4
+ Details
| Name: |
us-gaap_DebtInstrumentIncreaseAccruedInterest |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
credit |
| Period Type: |
duration |
|
| X |
- Definition
Net increase or decrease in the carrying amount of the debt instrument for the period for reasons other than accrued but unpaid interest, additional borrowings, forgiveness and repayments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph f
-Article 4
+ Details
| Name: |
us-gaap_DebtInstrumentIncreaseDecreaseOtherNet |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
credit |
| Period Type: |
duration |
|
| X |
- Definition
The average effective interest rate during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_DebtInstrumentInterestRateDuringPeriod |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
num:percentItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
Interest rate stated in the contractual debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_DebtInstrumentInterestRateStatedPercentage |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
num:percentItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
This web site and associated pages are not associated with, endorsed by, or sponsored by ENTEST BIOMEDICAL, INC. and has no official or unofficial affiliation with ENTEST BIOMEDICAL, INC.
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
|
|
